Two different timelines
“Kicking in” can mean two different things: when the drug’s biological effect starts, and when a person notices a change. Retatrutide’s appetite-suppressing effect typically begins within the first few days of the first injection, well before the starting dose is anywhere near a maintenance level. Noticeable weight change is a separate, slower timeline.
The first week
Reduced appetite and, for some people, mild nausea are usually the first signs anything is happening, often within 48 to 72 hours of the first dose. This happens even at the low starting dose, since GLP-1 receptor activity affects gastric emptying almost immediately.
When weight change becomes noticeable
Trial data shows measurable weight loss beginning within the first four weeks, but the more substantial changes reported in phase 2 and phase 3 trials built up over months, not weeks, and tracked closely with the titration schedule reaching higher dose steps.
Why the two timelines don’t match
The starting dose produces real appetite effects quickly, but it’s deliberately too low to drive large weight change on its own. Meaningful results build as the dose steps up, which is part of why a schedule that rushes through steps doesn’t necessarily produce faster results; the body still needs time to respond to each new level.
Setting expectations against the schedule
Someone in week one of a titration schedule and someone in week twelve are, biologically, in very different places, even if both technically “started retatrutide” the same number of weeks ago by a calendar. Comparing early results against someone further along a schedule usually isn’t a fair comparison.